Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

1 terminated out of 15 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results89% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (1)
P 2 (1)
P 3 (1)
P 4 (2)

Trial Status

Completed8
Unknown3
Enrolling By Invitation2
Not Yet Recruiting1
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT01718301Phase 3Terminated

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

NCT03800407Completed

Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection

NCT06779175Completed

Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized Adults

NCT06834178Not Yet Recruiting

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

NCT03800381Completed

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

NCT03800394Completed

Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents

NCT05318235Completed

Virus Interactions in the Respiratory Tract; a Cohort Study With Children

NCT02699736Enrolling By Invitation

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

NCT02414399Phase 4Unknown

Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children

NCT04984772Enrolling By Invitation

Prospective Cohort of HIV/HBV-coinfected Patients in Europe

NCT04410263Unknown

Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches

NCT03549312Phase 4Unknown

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

NCT02294136Not ApplicableCompleted

Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection

NCT02281643Phase 2Completed

Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana

NCT02325102CompletedPrimary

Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department

Showing all 15 trials

Research Network

Activity Timeline